Struggle for Drug Sales Regulation

Deputies of the Guatemalan Congress ask that the agreement that regulates the commercialization of antibiotics and ophthalmological steroids, recently approved by the Executive Branch, be repealed.

Tuesday, September 17, 2019

Controversy between representatives of the legislature and the executive began after the Ministry of Public Health and Social Assistance (MSPAS) approved Agreement 181-2019 on August 7, 2019, which stipulates that antimicrobial drugs (oral and parenteral antibiotics) and ophthalmic steroids must be sold with a prescription. See full agreement.

For the members of the Human Rights Commission of the Congress of the Republic, the measure is not suitable in a context where health services cannot cover the entire population.

See "Medications: Sales Regulated in Guatemala

For that reason, Health Minister Carlos Soto was summoned to Congress to discuss the issue, but he did not attend, and it was his team that presented to the deputies the arguments of why it is necessary to regulate the sale of these medicines.

In statements to Prensalibre.com, Soto said that "... There are some Members who indicate that we are violating the human rights of the population. They say this forces people to go to the doctor to get a prescription for the antibiotic, but that's what it's all about. The agreement goes on, that agreement I don't take away'.

You may be interested in "Pharmaceuticals: Imports at the end of 2018

Edna Soto, a congresswoman for the Todos party and a member of the Congressional Human Rights Commission, explained that she is not "... in agreement with the law because it prohibits the right of Guatemalans to acquire medicines for the treatment of illnesses. I am of the idea that before imposing a law you must first socialize it with the population, or that it is going to be harmful or benefited, to avoid these problems, but we are not going to issue laws taking into account that they can violate the human rights of people."

Because the regulation will begin to apply in the coming weeks, the parliamentary commission requests the Human Rights Ombudsman (DPH) to issue an appeal to annul the ministerial agreement.

According to reports from CentralAmericaData, during 2018 the main buyer of pharmaceutical products in Central America was Costa Rica, with $777 million, followed by Guatemala, with $656 million, Panama, with $620 million, Honduras, with $500 million, Nicaragua, with $375 million and El Salvador, with $364 million.

Do you need more information about your business sector?

Request more information about our services:

Name:

Last Name:

Company:

Title:

Phone:

Email:

Comments:

More on this topic

Deadline to Regulate Drug Sales

September 2019

The Ministry of Health of Guatemala published in the Official Newspaper the agreement that regulates the commercialization of antibiotics and ophthalmological steroids, and granted 30 days for pharmacies to begin to implement the restrictions.

The regulation that will begin to govern was approved by the Ministry of Public Health and Social Assistance (MSPAS) on August 7, and stipulates that antimicrobial drugs (oral and parenteral antibiotics) and ophthalmic steroids, must be sold after being prescribed. See full agreement.

Medications: Sales Regulated in Guatemala

August 2019

An agreement regulating the sale of antibiotics and ophthalmic steroids in the country was approved, which can now only be sold with a prescription.

On August 7, 2019, the Ministry of Public Health and Social Assistance (MSPAS) approved Agreement 181-2019, which stipulates that antimicrobial drugs (oral and parenteral antibiotics) and ophthalmic steroids must be sold after being prescribed.

Medications: Regulations Contradict Law

March 2013

Pharmaceutical unions in El Salvador have denounced the regulations determining maximum pricing as being contradictory to the Medicines Act

Elsalvador.com reports that the legal counsel for Fedefarma y Diprofa, Luis Chávez, explained that the pricing for drugs is based on the active ingredient and not on each product: "This is the same as me asking for a point of law establishing a price ceiling on mobile phones.

TECO Energy Sells Guatemalan Operations

October 2012

Due to the classification of TECO Guatemala as discontinued operations, TECO Energy is revising its earnings-per-share guidance from continuing operations for 2012 to a range between $1.10 and $1.20, excluding charges or gains.

TAMPA, September 28, 2012

TECO Energy (NYSE: TE) today announced that its international power subsidiary, TECO Guatemala, has entered into separate agreements to sell all of the equity interests in the Alborada and San José power stations and related solid fuel handling and port facilities in Guatemala for a total purchase price of $227.5 million in cash. The purchaser of the Alborada Power Station is Sur Electrica Holding Ltd. (SUR). The purchaser of the San José Power Stations and related solid fuel handling and port facilities is Renewable Energy Investments Guatemala Ltd. (REIN), a wholly-owned subsidiary of SUR. SUR and REIN are international companies organized under the laws of the Commonwealth of the Bahamas.

 close (x)

Receive more news about Health & Medicine

Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.

Type in your e-mail address:

* Al suscribirse, estará aceptando los terminos y condiciones


Girasol Pharma S.A.

Organization that operates in Panama, Panama, Costa Rica, Honduras, El Salvador, Nicaragua and Guatemala.
Phone: (507) 65456121

Girasol Pharma is a school of clinical pharmacist contracted for Santos de Rey Medical Group, where it participates in the activities of direct attention to the patient in the management of pharmacological therapy, geriatrics and anticoagulation clinics.

Company Profile

Stock Indexes

(Apr 6)
Dow Jones
-5.60%
S&P 500
-5.10%
Nasdaq
-5.64%

Commodities

(Dec 6)
Brent Crude Oil
64.270
Coffee "C"
123.95
Gold
1,462
Silver
16.51